Multiple studies have revealed that PD-1 impairs CD8+ CTL-induced anti-tumor immune responses (Hamanishi et al, 2007; Nomi et al, 2007), and anti-chronic viral infections including HIV, HBV, and HCV (Barber et al, 2006; Wherry et al, 2007). This evidence concerns the gene CD8A and neoplasm.